QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Dear Readers of Quest and Friends Of the Urological Research Foundation When Dr. Catalona developed the PSA test, he transformed the way prostate cancer was diagnosed, allowing for earlier detection and the saving of thousands of lives. Now, he and…
Why a patient’s column? This is not a doctor’s column. I am a patient of Dr. Catalona and a member of the URF Board. This column attempts to provide a patient’s perspective on prostate cancer to the readers of QUEST….
Each year, Dr. Catalona and his research collaborators deliver their research findings at the annual meeting of the American Urological Association (AUA). Although the information is technical, we feel that Quest readers would like to be familiar with the direction…
Even when the pathology report after a radical prostatectomy states that it looks like all of the cancer was confined to the prostate gland, some percentage of men have a recurrence of the cancer at a later date. In these…
Much publicity has been given to a new study suggesting that biopsies should be recommended for men whose PSA tests 2.6 or higher. (We introduced the study in the Fall 2003 QUEST and cover it extensively in this Winter 2003…
"*" indicates required fields
